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Mechanistic Target of Rapamycin Complex 1 (mTORC1) serves as positive regulator
of placental nutrient transport and mitochondrial respiration. The role of mTORC1
signaling in modulating other placental functions is largely unexplored. We used gene
array following silencing of raptor to identify genes regulated by mTORC1 in primary
human trophoblast (PHT) cells. Seven hundred and thirty-nine genes were differentially
expressed; 487 genes were down-regulated and 252 up-regulated. Bioinformatic
analyses demonstrated that inhibition of mTORC1 resulted in decreased expression
of genes encoding ribosomal proteins in the 60S and 40S ribosome subunits.
Furthermore, down-regulated genes were functionally enriched in genes involved in
eIF2, sirtuin and mTOR signaling, mitochondrial function, and glutamine and zinc
transport. Stress response genes were enriched among up-regulated genes following
mTORC1 inhibition. The protein expression of ribosomal proteins RPL26 (RPL26)
and Ribosomal Protein S10 (RPS10) was decreased and positively correlated to
mTORC1 signaling and System A amino acid transport in human placentas collected
from pregnancies complicated by intrauterine growth restriction (IUGR). In conclusion,
mTORC1 signaling regulates the expression of trophoblast genes involved in ribosome
and protein synthesis, mitochondrial function, lipid metabolism, nutrient transport, and
angiogenesis, representing novel links between mTOR signaling and multiple placental
functions critical for normal fetal growth and development.
Keywords: placenta, maternal–fetal exchange, human, nutrient sensor, energy metabolism, gene array
INTRODUCTION
Placental nutrient sensing is the process by which the syncytiotrophoblast cell integrates a
multitude of maternal and fetal nutritional cues through cellular nutrient sensing signaling
pathways to balance fetal nutrient demand with the ability of the mother to provide nutrients
and oxygen required for fetal growth (Jansson et al., 2012a). This is accomplished by regulating
maternal physiology and functions such as nutrient transport (Jansson and Powell, 2006, 2013;
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Jansson et al., 2012b; Larque et al., 2013) in the
syncytiotrophoblast, the epithelium that separates maternal
and fetal blood.
Mechanistic Target of Rapamycin (mTOR) is an evolutionarily
conserved serine/threonine kinase that is activated by amino
acids, folate, glucose, oxygen, and growth factor signaling and
promotes cell growth and metabolism. mTOR exists in distinct
two complexes, mTOR Complex 1 (mTORC1) and 2, with the
protein raptor associated to mTORC1 and rictor associated
to mTORC2. When activated, mTORC1 phosphorylates S6K1
and 4E-BP1 promoting protein translation, lipid biogenesis,
and metabolism as well as suppressing autophagy (Peng et al.,
2002; Jacinto and Hall, 2003; Hay and Soneneberg, 2004;
Martin and Hall, 2005; Tee and Blenis, 2005; Laplante and
Sabatini, 2012). mTORC2 phosphorylates Akt, PKCα, and Serum
and Glucocorticoid-regulated Kinase 1 (SGK1) and regulates
cytoskeletal organization and metabolism (Jacinto et al., 2004;
Alessi et al., 2009). Placental mTOR activity is decreased in
human intrauterine growth restriction (IUGR) (Roos et al., 2007;
Yung et al., 2008; Chen et al., 2015a) as well as in rodent
(Rosario et al., 2011) and non-human primate models of IUGR
(Kavitha et al., 2014). On the other end of the fetal growth
spectrum, placental mTOR activity is activated in obese women
giving birth to larger babies (Jansson et al., 2013) as well as
in a mouse model of maternal obesity associated with fetal
overgrowth (Rosario et al., 2015b). We previously demonstrated
that placental mTOR functions as a positive regulator of amino
acid transporter systems A and L (Rosario et al., 2013), folate
transporters (Rosario et al., 2016), and mitochondrial respiration
(Rosario et al., 2019). However, mTORC1 regulation of other
trophoblast functions remains largely unexplored.
Although well established as a master regulator of protein
translation, mTORC1 signaling is also involved in transcriptional
regulation. For example, mTORC1 modulates gene expression
by impacting the activity of transcription factors, including
STAT3, TFEB, NRF1, HIF1α, and YY1-PGC1α (Peng et al., 2002;
Cunningham et al., 2007; Duvel et al., 2010; Jimenez et al.,
2010; Wang et al., 2011; Laplante and Sabatini, 2013). Moreover,
pharmacological and genetic studies have demonstrated that
mTOR binds to the promoter and regulates the synthesis of Pol
I-transcribed 45S rDNA and Pol III-transcribed genes, including
genes critical for protein synthesis and cell growth such as tRNA
and 5S rRNA (Tsang et al., 2010).
The human placenta expresses more than 12,000 genes,
including most of the known imprinted genes (Dizon-Townson
et al., 2000). Common pregnancy complications, such as
preeclampsia, IUGR, preterm birth, and recurrent pregnancy
loss, are associated with impaired placentation and/or altered
placental function. Integrative transcriptome analysis revealed
dysregulation of canonical cancer molecular pathways in the
placenta in association with preeclampsia (Moslehi et al., 2013).
Emerging evidence demonstrates that placental function and
gene expression are altered in response to various stresses
and perturbations in the maternal environment (Osei-Kumah
et al., 2011). For example, feeding mice a high fat diet was
reported to influence placental gene expression (Mao et al.,
2010). In addition, supplementation with dietary n-3 long chain
polyunsaturated fatty acids to pregnant women altered the
placental transcriptome (Sedlmeier et al., 2014). To the best of
our knowledge, the regulation of the trophoblast transcriptome
by mTORC1 signaling has not been previously explored. In the
present study, we employed an unbiased discovery approach to
identify regulatory networks and novel regulators to attain a more
comprehensive understanding of mTORC1 regulation of gene
expression in primary human trophoblast (PHT) cells.
MATERIALS AND METHODS
Ethical Approval and Study Participants
All experimental protocols were approved by the Institutional
Review Board of the University of Texas Health Science Center
San Antonio. Placentas of uncomplicated term pregnancies were
collected with informed consent at the Labor and Delivery Unit
at the University Hospital San Antonio.
Isolation and Culture of Primary Human
Trophoblast (PHT) Cells
Placentas were collected immediately following delivery by
cesarean section at term without labor. PHT cells were isolated
and cultured in vitro using well-established protocols (Kliman
et al., 1986). Cells were plated in 60 mm culture dishes
(∼7.5× 106 cells/dish) and cultured in 5% CO2, 95% atmosphere
air at 37◦C for 90 h. Cell culture media (DMEM/Hams F-
12, supplemented with L-glutamine, penicillin, streptomycin,
gentamycin, and 10% fetal bovine serum) was changed daily.
Four independent biological replicates (n = 4 placentas) were
studied. Selected clinical characteristics of the study subjects are
provided in Table 1.
Assessment of Biochemical
Differentiation and Viability
To confirm that trophoblast cells were undergoing biochemical
differentiation, and to assess their viability with time in culture,
the release of human chorion gonadotropin (hCG) by trophoblast
cells into the culture medium 18, 42, 66, and 90 h after plating
was measured using a commercial ELISA kit, which detects
the β-subunit of hCG (Immuno Biological Labs). As a readout
TABLE 1 | Selected clinical characteristics of pregnancies used for isolation of
trophoblast cells.
Placenta 1 Placenta 2 Placenta 3 Placenta 4
Maternal age (years) 26.0 27.0 25.0 28.0
BMI (kg/m2) 24.5 23.5 22.5 23.0
Gestational age (weeks) 37.1 37.2 37.3 37.5
Birth weight (g) 2500 2645 2589 2679
Placental weight (g) 645 680 595 604
Fetal sex (M/F) M F M F
Mode of delivery (C/V) C C C C
Abbreviations: F, female; M, male; C, cesarean section; V, vaginal delivery.
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of apoptosis, protein expression of caspase-3 was determined
using Western blot.
RNA Interference-Mediated Silencing
Dharmafect 2 transfection reagent (Thermo Scientific, Rockford,
IL, United States) and small interfering RNAs (siRNAs) (Sigma–
Aldrich, St. Louis, MO, United States), targeting raptor (100 nM;
sense, 5′CAGUUCACCGCCAUCUACA) was used. Control cells
were transfected with a non-coding scrambled sequence (100 nM;
sense: 5′GAUCAUACGUGCGAUCAGATT). siRNA was added
to cultured primary trophoblast cells after 18 h in culture,
incubated for 24 h, and removed when fresh medium was added
to wells (Forbes et al., 2009).
Western Blotting
Efficiency of target silencing was determined at the protein
(expression of raptor) and functional levels (phosphorylation of
mTORC1 down-stream target; S6-Serine-235/236) using Western
blot. A 90 h culture PHT cells were rinsed once with ice-
cold PBS and lyzed in ice-cold buffer (PBS containing protease
and phosphatase inhibitors and 0.05% SDS). Subsequently, cells
were scraped, collected, and sonicated. The soluble fraction
of cell lysates was isolated by centrifugation at 13,000 g for
10 min at 4◦C. Total protein concentration in the cell lysate
was determined using Bradford’s reagent (Bio-Rad). Cell lysate
proteins (10 µg) were separated on 4–20% precast linear
gradient gels (Invitrogen). Membranes were incubated overnight
at 4◦C with primary antibody diluted in 1% non-fat milk
(wt/vol) in TBST and detected using an appropriate peroxidase-
conjugated secondary antibody. Products were visualized by
ECL chemiluminescence (Millipore). Band intensities were
measured using the G-box system (Syngene). Anti-raptor, S6-S-
235/236, Akt-S-473 antibodies were obtained from Cell Signaling.
Ribosomal Protein L26 (RPL26) and Ribosomal Protein S10
(RPS10) antibodies were obtained from AB clonal. Target
band densities were normalized to total protein (Ponceau)
stain as a loading control. For each protein target, the mean
density of the control sample bands was assigned an arbitrary
value of 1. All individual densitometry values were expressed
relative to this mean.
RNA Isolation From PHT Cells
RNA was isolated from cultured PHT cells at 90 h in
culture using TRIzol Reagent (Invitrogen, Carlsbad, CA,
United States) according to the manufacturer’s instructions. RNA
was resuspended in 100 µl DEPC-treated water. RNA quality
was determined using an Agilent 2100 Bioanalyzer (Agilent
Technologies, Inc., Santa Clara, CA, United States) and RNA
concentrations confirmed by quantitation using a NanoDropTM
8000 spectrophotometer (Thermo Fisher Scientific, Wilmington,
DE, United States).
Gene Expression Profiling in PHT Cells
Whole genome expression profiling was performed using gene
arrays (HumanHT-12 v4 Expression BeadChips, Illumina Inc.,
San Diego, CA, United States). cRNA was synthesized and biotin
labeled (cat. no. 1750, Ambion, Austin, TX, United States)
according to manufacturer’s instructions. Total RNA was used
for first and second strand cDNA synthesis followed by in vitro
transcription to synthesize biotin-labeled cRNA. cRNA was
quality checked and then hybridized to Human HT-12 v4
Expression BeadChips (Illumina Inc.). Individual cRNA samples
were used to interrogate each BeadChip (Scramble siRNA, n = 4;
Raptor siRNA, n = 4). Gene expression was detected and cleaned
using GenomeStudio software (Illumina Inc.) and filtered using
quality score > 0.95. Gene array data were all-median normalized
and log2 transformed (GeneSifter), and differentially expressed
genes were identified by t-test (p < 0.05).
Pathway Analysis
Genes significantly different in expression between raptor
silenced and scramble siRNA treated PHT were overlaid onto
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways
(Kanehisa and Goto, 2000; Kanehisa et al., 2016, 2017) using
GeneSifter. Z-scores were calculated in GeneSifter. Statistical
enrichment of differentially expressed genes in pathways was
determined by calculating z-scores using the following formula:
z-score = (r−n(R/N))/SQRT(n(R/N)(1−(R/N))(1−(n−1/N−1)),
where R = total number of genes meeting selection criteria,
N = total number of genes measured, r = number of genes
meeting selection criteria with the specified GO term, and
n = total number of genes measured with the specific GO
term. Pathway enrichment analysis of differentially expressed
genes has been shown to reveal pathways that are impacted
in that biological system (Bayerlova et al., 2015). KEGG is a
comprehensive knowledge base for assisting in the biological
interpretation of large-scale molecular datasets. Using KEGG
pathway enrichment analysis provides a means to statistically
filter gene expression data within the framework of annotated
biological systems (Kanehisa et al., 2017). Calculations were
performed using Gene Sifter software default settings without
user input. Pathways were considered significantly different
between groups if the z-score for that pathway was greater than
2.0 or less than 2.0 (Doniger et al., 2003). Biological pathways
were mapped by using online tool KEGG1 (Kyoto encyclopedia
for genes and genomes) (Ogata et al., 1999; Kanehisa and Goto,
2000; Kanehisa et al., 2016, 2017).
Network Analysis
The networks were generated through the use of IPA (QIAGEN
Inc.2) (Kramer et al., 2014). Network analysis [Ingenuity
Pathway Analysis (IPA), Ingenuity R© Systems, Redwood City,
CA, United States] was performed using differentially expressed
genes (p < 0.05) from each pairwise comparison. Networks
were built using the IPA Knowledge Base, using expression
profiles from this dataset and requiring direct connections
between molecules based on experimental evidence (Kramer
et al., 2014). Network significance was calculated in IPA using
Fisher exact t-test (Ingenuity R© Systems). The p-value for a given
network takes into account the number of eligible molecules
1http://www.genome.jp/kegg/
2https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis
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(differentially expressed genes) in the selected reference set
(defined by the Ingenuity Knowledge Base); the total number of
molecules in the selected reference set known to be associated
with that function; the total number of eligible molecules in
the selected reference set; and the total number of molecules
in the reference set (Ingenuity R© Systems). In this analysis, we
considered networks containing > 25 differentially expressed
genes and a p-value < 10−20 as significant.
Placental mTORC1 Signaling and
Expression of Ribosomal Proteins in
IUGR
Placentas from pregnancies complicated by IUGR and women
delivering appropriate-for-gestational age (AGA) infants were
collected within 15 min of delivery as described (Chen et al.,
2015a). Selected clinical data for the AGA and IUGR groups
are provided in Table 2. There was no significant difference
in maternal age, body mass index (BMI), or gestational age
between the control and the IUGR groups. Birth weight was
28% lower (P < 0.01) and placental weight was reduced by
36% (P < 0.001) in the IUGR group compared with AGAs.
The decidua basalis and chorionic plate were removed, and
villous tissue was dissected and rinsed in cold physiological saline.
The villous tissue was transferred to cold buffer D (250 mM
sucrose, 10 mM HEPES, pH 7.4) containing 1:100 dilution of
protease and phosphatase inhibitors (Sigma–Aldrich, St. Louis,
MO, United States) and homogenized on ice with a Polytron
(Kinematica, Luzern, Switzerland). Placental homogenates were
frozen in liquid nitrogen and stored at −80◦C until further
processing. The phosphorylation of key proteins in the mTORC1
[as reported in Chen et al., 2015a] and ribosomal protein (RPS10
and RPL26) expression in placental homogenates of IUGR and
AGA groups were determined using Western blots as described
above for PHT cells.
Data Presentation and Statistics
The number of experiments (n) represents the number
of individual placentas studied. Data are presented as
means ± SEM. Array data from each sample were all-median
TABLE 2 | Selected clinical data.
AGA (n = 19) IUGR (n = 25)
Maternal age (years) 25.9 ± 1.29 28.7 ± 1.23
BMI (kg/m2)* 28.3 ± 2.6 26.8 ± 2.0
Gestational age (weeks) 33.9 ± 0.95 35.7 ± 0.61
Birth weight (g) 2493 ± 236 1804 ± 110†
Birth weight percentile‡ 55.9 ± 4.6 2.4 ± 0.3§
Placental weight (g) 566 ± 42.0 394 ± 18.4parallel
Fetal sex (M/F) 7/12 8/17
Mode of delivery (C/V) 6/13 15/10
Data are presented as means ± SEM. Abbreviations: AGA, appropriate grown
for gestational age; IUGR, intrauterine growth restriction; F, female; M, male; C,
cesarean section; V, vaginal delivery. *Data from n = 10 AGA and 18 IUGR. ‡By
corresponding gestational age. †P < 0.05. ‖P < 0.01. §P < 0.0001.
normalized and log2 transformed. Box plots were inspected to
ensure that the median for each group was 0 and variance
among groups was similar. Statistical analyses of array
data were performed by t-test using Gene Sifter software
(Geospiza, Inc.) for pairwise comparisons (GeneSifter.Net,
VizX Labs, Seattle, WA, United States; GEO accession number:
GSE40878). Statistical significance of differences between control
and experimental groups in studies of protein expression
and ribosomal protein was assessed using Student’s t-test.
A P-value < 0.05 was considered significant.
RESULTS
Raptor Silencing in PHT Cells Inhibits
mTORC1 Signaling
Raptor siRNA markedly decreased the protein expression of
raptor (−75%, p = 0.001; n = 4/each group) and decreased the
phosphorylation of S6 ribosomal protein-Ser-235/236 (−84%,
p = 0.002; n = 4/each group), a functional readout for mTORC1
signaling (Figure 1). In contrast, raptor silencing did not
influence mTORC2 signaling, using Phospho-Akt serine 473
as a functional readout (Figure 1) demonstrating that raptor
silencing is specific for mTORC1 signaling and does not result
in a secondary activation of mTORC2. The hCG secretion
profiles (n = 4/each group) and caspase-3 (n = 4/each group)
expression were comparable between PHT cells transfected with
scrambled or raptor siRNA (Figure 1). These findings indicate
that raptor silencing did not affect differentiation/syncytialization
and viability of cultured PHT cells and suggest that the effects
of raptor silencing on the trophoblast transcriptome were not
caused by unspecific effects.
Genes Regulated by mTORC1 Signaling
in PHT Cells
The impact of mTORC1 inhibition (raptor silencing) on PHT
gene expression was determined by analyzing gene array data
comparing raptor siRNA with scramble siRNA. Inhibiting
mTORC1 significantly altered the expression of 739 genes, 252
were up-regulated and 487 were down-regulated (Figure 2).
Significantly impacted genes are listed in Supplementary Table 1.
Hierarchical Clustering of Differentially
Expressed Genes (DEGs)
We performed a hierarchical clustering of differentially expressed
genes using the heat map function. Rows correspond to genes and
columns to samples. In the heat map of Figure 2B, 739 differential
genes were analyzed. The genes with similar expression patterns
are clustered together. Among genes significantly up-regulated
in raptor silenced cells were those coding for proteins involved
in vascular smooth muscle contractions (PLA2G3, PPP1R12C,
CYP4A11, ROCK2, ADM), interleukin signaling pathways (IL-6),
transcriptional regulators of EGF-dependent pathways (ATF3),
and cellular response to stress (HLADQA, KIR3DL1, and
GPR150). Among the genes significantly down-regulated in
raptor silenced cells were those coding for proteins involved
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FIGURE 1 | Effect of raptor silencing on raptor protein expression, mTORC1 signaling activity, and trophoblast differentiation and viability. (A) Representative western
blots of raptor, phosphorylated S6 ribosomal protein (Ser-235/236) and total S6 ribosomal protein, and Caspase-3 expression in cell lysates of scramble siRNA and
raptor siRNA silenced cells. Equal loading was performed. (B) Summary of the western blot data of raptor, S6 ribosomal protein (Ser-235/236), and total S6
ribosomal protein. (C) Secretion of human chorionic gonadotropin (hCG) from PHT cells transfected with scramble or raptor siRNA. (D) Summary of the western blot
data of Caspase 3. Values are given as means + SEM. *P < 0.05 vs. scramble siRNA; unpaired Student’s t-test; n = 4/each group.
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FIGURE 2 | Differentially expressed genes in raptor siRNA vs scramble siRNA silenced PHT cells. (A) Heatmap of expression data for the differentially expressed
genes in raptor siRNA vs. scramble siRNA silenced PHT cells. Clustering of gene expression patterns reveals genes with functional correlations. (B) The number of
differentially expressed genes in raptor siRNA vs. scramble siRNA silenced PHT cells. The red represents up-regulated genes and blue represents down-regulated
genes in raptor silenced PHT cells as compared to cells transfected with scramble siRNA.
in glutathione metabolism (GSTK1, MGST3, SMS, GGCT) and
metabolic processes (AKR1A1, ACOT4, GALM, CMBL, COX6C,
COX7B, COX7C, B3GALNT2). Importantly, raptor silencing was
confirmed in the gene array by decreased expression of RPTOR,
whereas expression of RICTOR was unaffected (Figure 3).
Functional Analysis of Differentially
Expressed Genes in PHT Cells With
mTORC1 Inhibition
Gene ontology (GO) analysis of differentially expressed genes
using the ‘ShinyGOv06.1 bioinformatics tool provides insights
into biological processes, molecular functions, and cellular
components. Separate GO enrichment analysis for up-regulated
and down-regulated genes was performed. GO analysis suggested
that up-regulated genes were mainly involved in biological
processes including response to stress and regulation of
biological quality (Table 3), whereas down-regulated genes
primarily played a role in catabolic process, cellular component
biogenesis, and regulation of signaling (Table 4). In the cellular
component category, many down-regulated transcripts were
associated with vesicle, cytosolic ribosome, ribosomal subunit,
extracellular exosome/organelle/vesicle, and endomembrane
system (data not shown).
Ingenuity Pathway Analysis
Pathway analysis is considered a valuable tool in estimating
functions of genes in different systems (Allocco et al., 2004).
IPA revealed distinct GO enrichment in raptor silenced cells.
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FIGURE 3 | Raptor silencing down-regulated components of mTORC1 (RPTOR, RPS15 A, RPS28) but not mTORC2 signaling in PHT cells. Graphical
representation of PHT cell mTOR signaling networks identified by Ingenuity Pathway Analysis (IPA) following raptor silencing. Molecular relationships between genes
down-regulated (green) or up-regulated (red) or no change (white) in expression after raptor silencing are shown.
The top significantly enriched canonical signaling pathways
inhibited in raptor-silenced PHT cells were eIF2 signaling,
mitochondria dysfunction, sirtuin signaling, and mTOR signaling
(Figure 4), consistent with mTORC1 being a key regulator of
protein synthesis and oxidative phosphorylation (Thoreen et al.,
2012; Rosario et al., 2019). We used KEGG analysis to study
mTORC1 regulation of genes encoding for ribosomal proteins
in greater detail and found that nineteen genes were identified
as being significantly inhibited in raptor silenced PHT cells.
Specifically, Ribosomal protein S6 (RPS6), L26 like (RPL26L1),
L12 (RPL12) L18a (RPL18A), L21 (RPL21), L22 (RPL22), L23A
(RPL23A), L26 (RPL26), L36a like (RPL36AL), S9 (RPS9), S10
(RPS10), S12 (RPS12), S15a (RPS15A), S20 (RPS20), S27 (RPS27),
S28 (RPS28), and L23 (RPL23) as well as ubiquitin A-52
residue ribosomal protein fusion product 1 (UBA52) were down-
regulated (Figure 5), suggesting that inhibition of mTORC1
results in a broad and coordinated down-regulation of genes
encoding proteins involved in ribosomal function.
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39 Response to stress USP28 DEPDC5 BDKRB1 REC8 MASP1 OASL FIGN APOBEC3C UBE2V1 EPB41L4B MCM8 MDM2 IL6 TRIM26
PNPT1 ALAS2 ATF3 RFWD3 SPN CR1 ADCYAP1R1 PSEN1 CADM4 EZH2 GLP1R COL4A3BP MORC1 NFKBIZ ADM
ISG20 NUB1 KIR3DL1 ROCK2 LGALS3BP SH2B1 LCK PRTN3 LILRB3 HLA-DQA2
32 Regulation of response
to stimulus
CC2D1A MIB2 DEPDC5 MASP1 FIGN LCK SPRY4 IL6 EZH2 GRM4 MDM2 PNPT1 LGR5 ADM NETO1 NF2 CR1
ADCYAP1R1 PSEN1 CADM4 ARHGEF17 NFKBIZ RASA1 ATF3 SH2B1 RASAL3 RFWD3 UBE2V1 ROCK2 ICOS
KIR3DL1 HLA-DQA2
32 Regulation of biological
quality
MDGA1 USP28 PSEN1 SCN1B GLP1R CPLX2 SCN3B KLK1 MDM2 IL6 RASA1 ADM ADCYAP1R1 BDKRB1 EZH2
COL4A3BP LNPEP SPTBN5 CIZ1 ALAS2 NETO1 NF2 RASL10B LCK CYP4A11 FA2H MCM8 ROCK2 ZNF16 GRM4
SH2B1 PRTN3
30 Cellular localization COL4A3BP C16ORF70 RABL2A CPLX2 LCA5L TSNARE1 PACS2 TBC1D3C EXOC3L2 GGA1 PSRC1 MDM2
ADCYAP1R1 PSEN1 PLA2G3 BDKRB1 EZH2 CIZ1 NETO1 NF2 ROCK2 PAF1 MCM8 SCN3B LCK HAO2 GRM4
SPTBN5 RPL32 TCTN2
30 Regulation of molecular
function
SCN1B OASL LGR5 SCN3B SPRY4 TBC1D3C PSEN1 EZH2 GRM4 IL6 TRIM26 NETO1 ZNF16 LCK CR1




MASP1 OASL LCK APOBEC3C IL6 PAF1 HOXA7 TRIM26 PRTN3 SPN CR1 LILRB3 PSEN1 PLA2G3 BDKRB1 NFKBIZ
CPLX2 ALAS2 ICOS ISG20 HLA-DQA2 NUB1 RASAL3 KIR3DL1 ZNF16 COL4A3BP LNPEP SLC7A10 UBE2V1






76 Catabolic process PSMB1 SAMD4A ACAT1 ECHDC1 RBX1 ZC3H14 PSMA2 AKR1A1 MMP19 GALM QDPR HK3 SMPD1 ATG7 UBA52
APOC2 DECR1 NUDT1 SKP1 SPP1 RPL23 CYP19A1 AZIN1 PRDX3 HPRT1 ACOT4 BCAP31 APOBEC3G VPS41
SIRT2 SNX5 TREM2 TSPO PLA2G15 BLVRA APAF1 PLBD1 DDA1 NPL HINT2 ESD TMEM208 LSM3 VDAC1 PGAM4
PDXP YBX1 FEZ2 NRBP2 ATP6V0E1 RPS20 TYMP DYNLL1 RPL18A LSM5 RPS12 PCCB RPL22 RPL21 RPS10




VPS41 RPL26L1 GAR1 NDUFB3 NCKAP1L RPS10 ORMDL1 DYNC2LI1 SRP19 C10ORF90 VBP1 RPL26 MAPRE2
LSM3 RSL1D1 RPS27 NDUFAF3 ATG7 RPL12 RPL23A RPS28 PPM1A DECR1 UGDH RTN4 RAB32 KHDRBS1
PRMT1 TRA2B APIP GBP5 SEC13 H3F3A HPRT1 RXRA PDXP SIRT2 CNGB1 ACAT1 KCNC4 APAF1 GTF3A GLUL
BIN1 POLR1E RPS6 GCHFR G3BP2 PTPRO PDLIM5 GPBAR1 TSPYL1 EIF3CL NDUFB2 RAP2A NDUFA1 CHMP2A
NDUFB9 FCER1G FEZ2 HAUS7 FGD2 TCP1 HSPB11 DYNLL1 RBX1 TRIP11 SKP1 CENPL TUBA1A RPS9 NDUFV2
UBA52 APOC2
60 Regulation of signaling ATP2C1 LGALS1 PPM1A LGALS9 LRP5L DUSP2 CCKAR TXN TREM2 EZH2 AAK1 SPP1 RAP2A CYP19A1
TBC1D16 S100A4 TYMP SNX5 CA2 RTN4 RPL22 KCNC4 NENF APAF1 KHDRBS1 CHSY1 SERINC3 HAVCR2 GLUL
CTDSPL2 SOD1 FGD2 APIP PTPRO SEC13 FABP5 MAPRE2 IL16 ATP2A2 UFSP2 PFDN5 RPL23 DSTYK ARL6IP5
RPL26 SMPD1 BCAP31 LILRA5 PRMT1 PSMB1 GDI2 CNGB1 RBX1 PSMA2 ATP1B1 IFNAR2 BRD7 FPR1
ARHGAP30 UBA52
mTORC1 Inhibition Regulated an Array
of Molecular Signaling Pathways in PHT
Cells
Up-regulated (252) and down-regulated genes (487) were
mapped to the KEGG pathway database3. KEGG pathway
analysis of cells with raptor silencing identified 183 down-
regulated (Table 5) and 54 up-regulated pathways (Table 6).
Down-regulated pathways in response to mTORC1 inhibition
included amino sugar and nucleotide sugar metabolism,
biosynthesis of unsaturated fatty acids, cysteine and methionine
metabolism, glycolysis/gluconeogenesis, glyoxylate and
dicarboxylate metabolism, oxidative phosphorylation,
purine metabolism, pyrimidine metabolism, ribosome,
RNA polymerase, vitamin B6 metabolism, and sphingolipid
3http://www.genome.jp/kegg/
metabolism (Table 5). Furthermore, alpha-linoleic acid
metabolism, arachidonic acid metabolism, cell adhesion
molecule, retinol metabolism, RNA degradation, and vascular
smooth muscle contraction were among the pathways
up-regulated in response to mTORC1 inhibition (Table 6).
Network Analysis
Network analysis of RNA expression in PHT cells with
inhibition of mTORC1 (raptor silencing) compared with control
cells (scramble) revealed three networks (Supplementary
Figures 1–3). The top annotated functions of the genes
composing the networks included: lipid metabolism, nutrient
transport, small molecule biochemistry, connective tissue
disorder, developmental disorder, hereditary disorder, post-
translational modification, cell signaling, drug metabolism,
cell morphology, cellular compromise, cellular function and
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FIGURE 4 | Overall functional analysis. Analysis of the top molecular and cellular functions determined by IPA for the raptor siRNA silenced PHT cells. (A) Ingenuity
Pathway Analyses (IPA) of array data identified canonical pathways significantly affected by raptor silencing in PHT cells. (B,C) ER stress and SIRT2 signaling
response genes are prominently affected in raptor silenced PHT cells. Color index represents gene expression changes, the red represents up-regulated genes, and
the blue represent down-regulated genes in raptor silenced PHT cells as compared to cells transfected with scramble siRNA.
maintenance, metabolic disease, carbohydrate metabolism,
embryonic development, organismal development, tissue
development, DNA replication, recombination, and repair,
neurological disease, organismal injury, and abnormalities.
Evaluation of these networks showed a coordinated response
to raptor silencing with the majority of genes down-regulated
(Supplementary Figures 1–3).
Placental mTORC1 Signaling Is
Associated With the Protein Expression
of RPL26 and RPS10 in Human
Pregnancy
To explore the clinical relevance of our findings, we examined
the relationship between placental mTORC1 signaling and
protein expression of ribosomal proteins RPL26 and RPS10
in placentas collected from AGA and IUGR pregnancies. The
protein expression of RPL26 (Figure 6) and RPS10 (Figure 7)
was significantly reduced in IUGR placentas. Placental mTORC1
signaling in the same placentas has been reported elsewhere
(Chen et al., 2015a). Phosphorylated 4E-BP1 (Thr-37/46) was
used as a placental mTORC1 signaling functional readout and
was positively correlated with RPL26 (Figure 6) and RPS10
(Figure 7) expression in AGA and IUGR placentas.
Placental Protein Expression of RPL26
and RPS10 Is Associated With
Microvillus Membrane (MVM) System A
Amino Acid Transport in Human
Pregnancy
System A is a ubiquitous Na+-dependent transporter that
transports small, zwitterionic, neutral amino acids with short,
unbranched side chains, such as alanine, serine, and glutamine
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FIGURE 5 | Raptor silencing induces expression changes in ribosome subunit genes. KEGG pathway database regulation of ribosome biogenesis is
over-represented in raptor silenced PHT cells as compared to cells transfected with scramble siRNA. The green box indicates down-regulated genes in raptor
silenced PHT cells as compared to cells transfected with scramble siRNA. The black box indicates no significant change in expression.
(Johnson and Smith, 1988). The activity of system A has
been consistently shown to be lower in syncytiotrophoblast
microvillous plasma membranes (MVM) isolated from IUGR
placentas (Mahendran et al., 1993; Glazier et al., 1997; Chen
et al., 2015a). We examined the relationship between placental
protein expression of ribosomal proteins RPL26 and RPS10 and
MVM system A amino acid transport in placentas collected
from AGA and IUGR pregnancies. Placental MVM system
A amino acid transport in the same placentas has been
reported elsewhere (Chen et al., 2015a). As shown in Figure 8,
placental protein expression of RPL26 and RPS10 was positively
correlated with MVM system A amino acid transport in AGA
and IUGR placentas.
DISCUSSION
We report for the first time mTORC1 regulation of the
trophoblast transcriptome in PHT cells, which contributes to
the relevance of our studies to human pregnancy. mTORC1
inhibition predominantly resulted in down-regulation of genes
(66% of the differentially expressed genes) and these genes
encode primarily for ribosome subunits and proteins involved
in protein synthesis, oxidative phosphorylation, and nutrient
transport. These findings agree with the well-established role
of mTOR signaling in modulating cell metabolism, growth,
and proliferation. In contrast, genes involved in responses
to stress were enriched among up-regulated genes following
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TABLE 5 | Down-regulated KEGG pathways in PHT cells in response to raptor silencing.
KEGG pathways Down Diff regulated genes Up Down Gene set z-score (Down)
Amino sugar and nucleotide sugar metabolism 4 0 4 47 2.65
Biosynthesis of unsaturated fatty acids 3 0 3 21 3.47
Butirosin and neomycin biosynthesis 1 0 1 5 2.51
Cardiac muscle contraction 5 0 5 73 2.4
Cysteine and methionine metabolism 3 0 3 35 2.31
Glutathione metabolism 4 0 4 50 2.5
Glycolysis/Gluconeogenesis 5 0 5 65 2.7
Glycosphingolipid biosynthesis – ganglio series 2 0 2 15 2.69
Glyoxylate and dicarboxylate metabolism 4 1 3 18 3.86
Metabolic pathways 54 5 49 1080 4.76
Oxidative phosphorylation 11 0 11 119 4.76
Propanoate metabolism 3 0 3 32 2.5
Purine metabolism 10 2 8 157 2.11
Pyrimidine metabolism 7 1 6 95 2.4
Ribosome 19 1 18 88 10.87
RNA polymerase 3 0 3 28 2.79
Vitamin B6 metabolism 1 0 1 5 2.51
Table lists KEGG pathways that were significantly down-regulated in PHT cells with raptor silencing as compared to control cells. “List” denotes the total number of
differentially expressed genes on the array. “Up” denotes the number of up-regulated genes. “Down” denotes the number of down-regulated genes. “Gene set” denotes
the total number of genes in this pathway that are included on the array and give a signal with PHT cell RNA. “Z-score” denotes the z-score for the list pathway.
TABLE 6 | Up-regulated KEGG pathways in PHT cells in response to raptor silencing.
KEGG pathways Up Diff regulated genes Up Down Gene Set z-score (Up)
alpha-Linolenic acid metabolism 1 1 0 17 2.38
Antigen processing and presentation 3 2 1 66 2.08
Arachidonic acid metabolism 2 2 0 55 2.4
Cell adhesion molecules (CAMs) 5 4 1 127 3.05
Complement and coagulation cascades 3 3 0 68 3.4
Graft-vs.-host disease 4 3 1 35 5.23
Intestinal immune network for IgA production 4 3 1 44 4.55
Neuroactive ligand–receptor interaction 9 6 3 312 2.34
Other glycan degradation 1 1 0 17 2.38
Primary immunodeficiency 2 2 0 35 3.31
Renin–angiotensin system 1 1 0 17 2.38
Retinol metabolism 3 2 1 51 2.55
RNA degradation 5 2 3 69 2
Staphylococcus aureus infection 5 2 3 51 2.55
Vascular smooth muscle contraction 5 5 0 123 4.16
Table lists KEGG pathways that were significantly up regulated in PHT cells with raptor silencing as compared to control cells. “List” denotes the total number of differentially
expressed genes on the array. “Up” denotes the number of up-regulated genes. “Down” denotes the number of down-regulated genes. “Gene set” denotes the total
number of genes in this pathway that are included on the array and give a signal with PHT cell RNA. “Z-score” denotes the z-score for the list pathway.
raptor silencing. In addition, we provide evidence that placental
expression of ribosomal proteins RPL26 and RPS10 was
decreased and positively correlated to mTORC1 signaling activity
and system A amino acid transport in placentas from pregnancies
complicated by IUGR. These findings suggest that our findings in
cultured trophoblast cells have relevance to clinically important
pregnancy complications.
The eIF2 alpha and eIF4-p70S6K signaling pathways
were significantly down-regulated by mTORC1 inhibition
in PHT cells. This finding has potential clinical relevance
because of reports in the literature describing an association
between inhibition of placental eIF2 alpha-eIF4-mTOR
signaling and restricted fetal growth (Yung et al., 2008;
Chen et al., 2015b). The eIF2, eIF4, and p70S6K signaling
pathways overlap and play an essential role in the regulation
of translation. We observed a significant reduction in the
transcript levels of genes encoding a number of ribosomal
proteins in the 60S (RPL30, RPL10A, RPL38, RPL22, RPL26,
RPL18A, RPL12, RPL31) and 40S (RPS12, RPS15A, RPS10,
RPS14, RPS6, RPS27) ribosome subunits in response to
mTORC1 inhibition in PHT cells, which is consistent with
previous reports demonstrating that mTORC1 controls
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FIGURE 6 | Expression of RPL26 in placental homogenates and correlation between placental mTORC1 functional readout 4EBP-T-37/46 and protein expression of
RPL26. (A) Protein expression of RPL26 in placental homogenates of AGA and IUGR group. Representative Western blot is shown. (B) Relative expression of
RPL26 in placental homogenates of AGA and IUGR. After normalization to β-actin, the mean density of AGA samples was assigned an arbitrary value of 1.
Subsequently, individual IUGR density values were expressed relative to this mean. (C) Correlation between placental mTORC1 functional readout 4E-BP1 T-37/46
and RPL26 expression. r = Pearson correlation coefficient, n = AGA, 19; IUGR, 25. Values are given as means ± SEM; *P < 0.05 vs. AGA; unpaired Student’s t-test.
the synthesis of ribosomal proteins in other cell types
(Iadevaia et al., 2012).
Knocking down of RPS10 and RPL26 in HeLa cells led to
decreased levels of 18S rRNA, indicating that they are necessary
for the assembly of the small subunit (Doherty et al., 2010).
Other studies demonstrated alterations of pre-RNA processing
and decreased assembly of small or large ribosomal subunits in
human cells with RPS10 and 26 deficiency (Collins et al., 2018;
Liu et al., 2018). We demonstrated that protein expression of
ribosomal proteins RPL26 and RPS10 was decreased in human
IUGR placentas. Furthermore, global deficiency in RPS10 and
RPL26 genes is associated with growth retardation and congenital
malformations (Clinton and Gazda, 1993). It is possible that
reduction of RPS10 and RPL26 in IUGR placenta may affect
the function of the proteins in rRNA processing, ribosome
biogenesis, and protein synthesis. Thus, mTORC1 signaling
inhibition in IUGR placentas(Chen et al., 2015b; Rosario et al.,
2015a) could potentially result in compromised function since
these cellular subunits play a central role in protein synthesis and
cellular energetics (Rosario et al., 2019). In general agreement
with this suggestion, several studies have provided evidence for
inhibition of protein synthesis in different tissues in IUGR (Du
et al., 2005; Regnault et al., 2005).
Raptor silencing also resulted in decreased expression of genes
encoding proteins involved in the initiation of protein synthesis.
For example, the transcript levels of EIF3C/EIF3L complex,
which activates protein synthesis, and the expression of YBX1,
which regulates translation, were significantly decreased in PHT
cells with mTORC1 inhibition. The protein synthetic capacity
of cells depends on the abundance of ribosomes and transfer
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FIGURE 7 | Expression of RPS10 and correlation of placental mTORC1 functional readout 4EBP-T-37/46 and protein expression of RPS10. (A) Protein expression
of RPS10 in placental homogenates of AGA and IUGR group. Representative Western blot is shown. (B) Relative expression of RPS10 in placental homogenates of
AGA and IUGR. After normalization to β-actin, the mean density of AGA samples was assigned an arbitrary value of 1. Subsequently, individual IUGR density values
were expressed relative to this mean. (C) Correlation between placental mTORC1 functional readout 4E-BP1 T-37/46 and RPSL6 expression. r = Pearson
correlation coefficient, n = AGA, 19; IUGR, 25. Values are given as means ± SEM; *P < 0.05 vs. AGA; unpaired Student’s t-test.
RNAs (tRNAs). Transcription of ribosomal RNAs (rRNAs)
and tRNAs by RNA polymerases I and III (Pol I and Pol III)
accounts for as much as 80% nuclear transcriptional activity
and is under tight control by growth factors and nutrients
through the mTOR pathway (Warner, 1999). The expression
levels of POLR2, which encodes the seventh largest subunit
of RNA polymerase II (RNAPII), were significantly reduced
in response to raptor silencing. In addition, the expression
of GPN3, a small GTPase required for proper localization
of RNAPII, was reduced in PHT cells following mTORC1
inhibition. Collectively, these observations are in line with
a well-established role of mTORC1 in regulating protein
translation and demonstrate, for the first time, that inhibition
of mTORC1 signaling results in down-regulation of multiple
genes encoding for proteins in the translational machinery in
PHT cells. Given the reports demonstrating placental mTOR
signaling is reduced in pregnancies complicated by IUGR
(Yung et al., 2008; Chen et al., 2015a; Rosario et al., 2015a;
Dimasuay et al., 2017; Hung et al., 2017) and activated in
placentas associated with fetal overgrowth (Jansson et al.,
2013; Martino et al., 2016; Muralimanoharan et al., 2016;
Sati et al., 2016; Shang and Wen, 2018), it is possible that the
transcriptional regulation of placental protein translation
contributes to these abnormal fetal growth phenotypes
in pregnant women.
One interesting observation from our study was that
mTORC1 inhibition decreased the abundance of the transcript
for BPGM (2, 3-bisphosphoglycerate mutase), an enzyme
generating 1,3-BPG, which promotes release of oxygen
from maternal hemoglobin at the maternal-fetal interface.
Decreased BPGM expression may impair oxygen transfer across
the placental barrier (Pritlove et al., 2006) when mTORC1
signaling is inhibited.
Fatty acid transporter 1 (FATP1) is a member of the
solute carrier family 27, which facilitates the cellular uptake
of long-chain fatty acids and FABP4 regulates intracellular
lipid trafficking and placental lipid transport and accumulation
(Makkar et al., 2014). Interestingly, the expression of FATP1,
FABP4, and SREBP1, which is a transcriptional activator required
for lipid homeostasis, was decreased in raptor silenced PHT cells.
These findings are consistent with previous reports that mTORC1
promotes lipid synthesis by activating the transcription factor
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FIGURE 8 | Correlation between placental protein expression of ribosomal
protein RPL26/RPS10 and microvillus membrane system A amino acid
transport in human pregnancy. (A) Correlation between placental protein
expression of RPL26 and MVM system A amino acid transport in AGA and
IUGR human pregnancy. (B) Correlation between placental protein expression
of RPS10 and MVM system A amino acid transport in AGA and IUGR human
pregnancy. r = Pearson correlation coefficient, n = AGA, 12; IUGR, 14.
SREBP-1 (Bakan and Laplante, 2012) and identifies mTORC1 as
a key regulator of placental lipid transport and metabolism.
VEGF signaling controls vascular function and angiogenesis,
which are critical processes for normal placental function and
fetal development (Cheung, 1997). Our data show that mTORC1
inhibition decreases the expression of VEGF in PHT cells,
which is in agreement with previous reports showing that
rapamycin inhibits VEGF production and signaling in mice
adenocarcinoma (Guba et al., 2002). These observations are
consistent with the finding that IUGR induced by maternal
dexamethasone treatment in the rat is associated with mTORC1
inhibition and decreased expression of angiogenic factors in
the placenta (Ozmen et al., 2015). Furthermore, mTORC1
inhibition in PHT cells decreased the expression of CRELD1,
a member of a subfamily of epidermal growth factor-related
proteins. This may be relevant for placental angiogenesis because
CRELD1 knock out in mice caused placental abnormalities
and global vascular insufficiency in the fetus (Natale et al.,
2006). Collectively, these data implicate trophoblast mTORC1 in
promoting placental angiogenesis.
Down-regulated transcripts belonging to plasma membrane
cellular component category included KCNC, SLC38A6,
SLC30A5, and DSTYK. SLC38A6 [sodium-coupled amino acid
transporter-6 (SNAT-6)] is involved in the regulation of the
placental glutamate–glutamine cycle, which has been associated
to fetal growth (Wu et al., 2015; Simner et al., 2017; McIntyre
et al., 2019). SLC30A5 encodes a zinc transporter-5 (ZnT5)
protein which is localized at the apical membrane of the placental
syncytiotrophoblast and believed to play an essential role in the
transfer of Zn to fetus. ZnT5 has also been shown to regulate
ribosome biogenesis (Ogo et al., 2015). We recently demonstrated
that placental mTOR regulates trophoblast nutrient transporters
at the post-translational level. Specifically, mTOR functions
as a positive regulator of amino acid transporter systems A
and L (Rosario et al., 2013) and folate transporters (Rosario
et al., 2016) by modulating the plasma membrane trafficking of
specific transporter isoforms. These findings together with the
demonstration in the current study that mTORC1 also regulates
specific trophoblast nutrient transporters at the transcriptional
level suggest that trophoblast mTOR is a master regulator of a
range of placental nutrient transporters mediated by distinct
molecular mechanisms.
We also observed a decrease in the expression of genes
involved in redox regulation, such as GPX1, following mTORC1
inhibition in PHT cells. The expression of CLPP, an ATP-
dependent peptidase in the inner mitochondrial membrane,
which is involved in the activation of the mitochondrial protein
unfolding response (Haynes et al., 2007), was also decreased in
raptor silenced cells. We observed a significant reduction in the
transcript levels of a number of mitochondrial ribosomal proteins
in the 39S (MRL18, MRL16) and 28S (MRPS34) ribosome
subunits in PHT cells following mTORC1 inhibition, which
is in line with previous reports that mTORC1 controls the
synthesis of mitochondrial ribosomal proteins in MCF7 cells
(Morita et al., 2015).
One potential limitation of our study is that we used a
single siRNA to silence raptor, which could be associated with
off-target effects. However, BlastN analysis demonstrated that
our raptor siRNA was not complementary to any other gene
sequence. In addition, we have demonstrated that raptor silencing
(mTORC1 inhibition) in PHT cells did not affect mTORC2
signaling (Rosario et al., 2013), suggesting high specificity in
targeting mTORC1. Moreover, in unpublished studies, we used
co-transfection of rictor siRNA (to inhibit mTORC2) and siRNA
targeting DEPTOR (an endogenous inhibitor of both mTORC1
and 2) to specifically activate mTORC1 in PHT cells. Importantly,
stimulation of mTORC1 activated PHT functions, including
amino acid transport, that are inhibited by our raptor siRNA
(unpublished). These observations strongly suggest that the
raptor siRNA used specifically inhibits mTORC1 signaling and
that significant off-target effects are unlikely.
CONCLUSION
Mechanistic Target of Rapamycin Complex 1 signaling regulates
the expression of trophoblast genes involved in ribosome and
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protein synthesis, mitochondrial function, lipid metabolism,
nutrient transport, and angiogenesis, representing novel links
between mTOR signaling and placental functions critical for
normal fetal growth and development. Because placental mTOR
signaling is inhibited in IUGR and activated in fetal overgrowth,
we propose that regulation of the placental transcriptome by
mTOR signaling directly contributes to altered placental function
and fetal growth in common pregnancy complications.
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